Similar Papers

Paper Title
Journal
Date
Author
Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy
Maureen J Lage ... Kristina S Boye
Advances in Therapy | VOL. 26
Maureen J Lage, et. al.Maureen J Lage ... Kristina S Boye
01 Feb 2009
PDB42 - Economic Impact of Diabetes Self-Management Education
Ee Chinaeke ... G Reeder
Value in Health | VOL. 21
Ee Chinaeke, et. al.Ee Chinaeke ... G Reeder
01 May 2018
Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts
Jane Castelli-Haley ... Kenneth Johnson
Journal of Medical Economics | VOL. 13
Jane Castelli-Haley, et. al.Jane Castelli-Haley ... Kenneth Johnson
28 Jul 2010
Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Melissa Young ... Greg L Plosker
PharmacoEconomics | VOL. 19
Melissa Young, et. al.Melissa Young ... Greg L Plosker
01 Jan 2001
View more papers

More From: PharmacoEconomics & Outcomes News

Paper Title
Journal
Date
Author
SAPIEN 3 TAVI cost effective vs surgical valve replacement for severe aortic stenosis in France
-
PharmacoEconomics & Outcomes News | VOL. 893
--
01 Dec 2021
A Fond Farewell from PharmacoEconomics & Outcomes News
-
PharmacoEconomics & Outcomes News | VOL. 893
--
01 Dec 2021
Radiation therapy cost-effective option for low-risk localised prostate cancer in Australia
-
PharmacoEconomics & Outcomes News | VOL. 893
--
01 Dec 2021
Indacaterol/glycopyrronium/mometasone cost effective in Canada
-
PharmacoEconomics & Outcomes News | VOL. 893
--
01 Dec 2021
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.